Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated (VRTX) — Form 144: Proposed sale of shares
AI-generated summary
Officer Charles F. Jr Wagner proposed to sell 15,286 shares of Vertex Pharmaceuticals Incorporated Common Stock with an aggregate market value of $8,374,740.82 through Fidelity Brokerage Services LLC. The proposed sale date is November 12, 2026. The trading plan was adopted on August 10, 2026.
Key facts
- Seller
- WAGNER CHARLES F JR
- Relationship
- Officer
- Shares to sell
- 15,286
- Market value
- $8,374,740.82
- Approximate sale date
- Nov 12, 2026
- Broker
- Fidelity Brokerage Services LLC
- Acquired (1)
- Nov 14, 2023 · ESPP Purchase
- Acquired (2)
- Nov 14, 2024 · ESPP Purchase
- Acquired (3)
- Feb 20, 2024 · Restricted Stock Vesting
- Acquired (4)
- May 14, 2024 · ESPP Purchase
- Acquired (5)
- Feb 10, 2025 · Restricted Stock Vesting
- Acquired (6)
- Feb 17, 2025 · Restricted Stock Vesting
- Acquired (7)
- Feb 24, 2025 · Restricted Stock Vesting
- Acquired (8)
- Feb 26, 2025 · Restricted Stock Vesting
- Acquired (9)
- May 14, 2025 · ESPP Purchase
Rule 10b5-1 plan · adopted Aug 10, 2026
More VRTX filings
- 4
Filed Nov 10, 2026
- 144
Filed Nov 6, 2026
- 10-Q
Filed Nov 3, 2026
- 8-K
Filed Nov 2, 2026
- 4
Filed Oct 22, 2026
- 3
Filed Oct 22, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.